ea0041ep858 | Pituitary - Basic | ECE2016
Korthower Daniela
, Monteserin-Garcia Jose
, Wu Yonghe
, Stalla Johanna
, Buchfelder Michael
, Rachinger Walter
, Stalla Gunter K.
, Renner Ulrich
The chemotherapeutic agent temozolomide (TMZ) has been applied for the treatment of pituitary carcinomas, atypical pituitary adenomas and prolactinomas resistant to dopamine agonist treatment with considerable success. Both shrinkage of the tumors and a drop of excessive hormone production were observed in TMZ-responsive patients. In order to clarify whether the TMZ-induced suppression of hormone secretion was a consequence of tumor shrinkage or caused by direct effects on hor...